Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	2.42	14.56	14.22
Graham Fair Price	0.34	0.02	0.02
PEG	-67.24	0.12	-0.36
Price/Book	86.50	1.30	0.70
Price/Cash Flow	24.02	22.58	-18.20
Prices/Earnings	-53.20	11.74	25.08
Price/Sales	-53.20	2.25	4.80
Price/FCF	24.02	22.58	-18.20
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.22	0.22
Operating Margin	-1.85	0.12	0.12
ROA	100.00	0.01	< 0.005
ROE	< 0.005	0.03	298.48
ROIC	0.01	0.03	112.59
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	7.37	-0.22	3310.51
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	-0.15	0.96	545.85
EPS QOQ	-0.70	1.00	42.86
FCF QOQ	-453.99	1.75	-99.61
Revenue QOQ	-0.49	1.00	103.57
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	20.48	10.24	-50.00
Days Sales Outstanding (DSO)	137.80	119.66	-13.16
Inventory Turnover	4.39	8.79	100.00
Debt/Capitalization	0.06	0.50	677.64
Quick Ratio	2.91	3.59	23.14
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.05	0.02	-49.73
Cash	0.02	0.02	-0.98
Capex	< 0.005	< 0.005	-0.15
Free Cash Flow	< 0.005	< 0.005	-24.41
Revenue	< 0.005	0.01	100.31
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	3.75	3.75	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.96	3.95	-55.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating